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Autism spectrum disorder (ASD) is one of the most widespread neurodevelopmental
disorders, characterized by impairment in social interactions, and restricted stereotyped
behaviors. Using immunohistochemistry and positron emission tomography (PET),
several studies have provided evidence of the existence of activated microglia in
ASD patients. Recently, we developed an animal model of ASD using the new world
monkey common marmoset (Callithrix jacchus) and demonstrated ASD-like social
impairment after the in utero administration of valproic acid (VPA). To characterize
microglia in this marmoset model of ASD from early toddler to adult, morphological
analyses of microglia in VPA marmosets and age-matched unexposed (UE) marmosets
were performed using immunohistochemistry for microglia-specific markers, Iba1, and
P2RY12. The most robust morphological difference between VPA marmosets and UE
marmosets throughout the life span evaluated were the microglia processes in VPA
marmosets being frequently segmented by thin and faintly Iba1-positive structures.
The segmentation of microglial processes was only rarely observed in UE marmosets.
This feature of segmentation of microglial processes in VPA marmosets can also be
observed in images from previous studies on ASD conducted in humans and animal
models. Apoptotic cells have been shown to have segmented processes. Therefore,
our results might suggest that microglia in patients and animals with ASD symptoms
could frequently be in the apoptotic phase with high turnover rates of microglia found in
some pathological conditions.
Keywords: microglial morphology, active microglia, autism spectrum disorder, segmented processes, marmoset
INTRODUCTION
Autism spectrum disorder (ASD) is one of the most widespread neurodevelopmental disorders
affecting approximately 1% of the world population and is characterized by impairment in
social interactions and communication and by restricted stereotyped behaviors (Lai et al.,
2014; Christensen et al., 2016). Microglia contribute to brain development, shaping of
neuronal ensembles, synaptic plasticity, and synaptic pruning under physiological conditions
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(Kettenmann et al., 2011; Paolicelli and Ferretti, 2017; Wolf
et al., 2017). Microglia are also thought to be related to the
neuropathology of ASD (Tay et al., 2018).
It has been proposed that microglia in ASD patients are in
activated states. For instance, postmortem studies have found
altered microglia morphology with its activated form in the
cerebral cortex of individuals with autism (Morgan et al., 2010).
Positron-emission tomography (PET) study of human brain
with the radiotracer [11C](R)-PK11195, a ligand for translocator
protein (TSPO) expressed in microglia and astrocytes, showed
increased [11C](R)-PK11195 binding in the brains of young
adults with ASD (Suzuki et al., 2013). Moreover, genome-wide
transcriptional analyses of postmortem brains revealed that some
individuals with autism exhibited exaggerated M2 activation
states, which are responsible for mediating anti-inflammatory
remediation (Gupta et al., 2014). However, the bimodal scheme
(M1 and M2 state) of microglia has been challenged (Ransohoff,
2016), and functional responses and morphological changes are
currently thought to differ depending on the types and conditions
of particular diseases (Kettenmann et al., 2011).
Although the etiology of ASD currently remains elusive,
maternal environmental factors, including stress, infection,
and intake of specific drugs, have been associated with ASD
(Dietert et al., 2011). Prenatal exposure to the anti-epileptic
drug, valproic acid (VPA), causes autistic behavior in children
(Williams and Hersh, 1997; Williams et al., 2001). Based on these
observations, VPA exposure in utero in rodents and common
marmosets (Callithrix jacchus) has become a popular tool for
creating animal models of ASD with face and construct validity
(Roullet et al., 2013; Servadio et al., 2015; Yasue et al., 2015,
2018; Bronzuoli et al., 2018; Nicolini and Fahnestock, 2018;
Mimura et al., 2019).
In the current study, we performed an in-depth analysis
of microglia morphology in marmosets prenatally exposed to
VPA (VPA marmosets) as an animal model of ASD from
early toddler stage to adulthood. This analysis was performed
using immunohistochemistry for Iba1 and P2RY12, microglia-
specific markers. Our investigation revealed that the robust
differences between VPA and unexposed (UE) marmosets
throughout the life span evaluated were the microglia processes
of VPA marmosets being frequently segmented by thin and
faintly Iba1-positive structures; however, this phenomenon
was only rarely observed in UE marmosets. This feature of
segmentation of microglial processes in VPA marmosets can also
be observed in images obtained from previous studies on ASD
conducted in humans and animal models (Morgan et al., 2010;
Jawaid et al., 2018).
MATERIALS AND METHODS
Animals
A total of 28 common marmosets (C. jacchus) were used
in this study, including 14 UE marmosets (9 males and five
females) and 14 VPA marmosets (five males and 9 females).
The animals were raised in-house until the ages of 2 months
(2M: 4 UE marmosets and 4 VPA marmosets), 3 months
(3M: 4 UE marmosets and 4 VPA marmosets), 6 months (6M: 4
UE marmosets and 4 VPA marmosets), and adulthood (1.6–
2.8 years: 2 UE marmosets and 2 VPA marmosets) (see Table 1
for details). According to Oga et al. (2013) and Sasaki et al.
(2015), the developmental ages for analysis were selected. The
ages of 2M, 3M, 6M, and later years correspond to early and late
toddler (when ASD symptoms first appear), early adolescence,
and adulthood, respectively (McKinnell et al., 2001; Chandolia
et al., 2006). All animal experiments were performed according to
the Guide for the Care and Use of Laboratory Animals (National
Institutes of Health, Bethesda, MD, United States) and approved
by the Animal Research Committee of the National Institute of
Neuroscience (Kodaira, Japan).
Preparation of VPA Marmosets
For the VPA group of marmosets, the dams were mated
in their pair cages. To determine the timing of pregnancy,
blood samples were collected from the femoral veins of
unanesthetized marmosets and blood progesterone levels were
monitored. A maximum of 0.3 mL blood was drawn from
each animal every Tuesday and Friday in the month that
pregnancy was predicted. The dams received oral doses of
TABLE 1 | Characteristics of the animals used in this study.
Age Treatment Postnatal day Sex




























UE, unexposed animals; VPA, valproic acid-exposed animals; 2 M, 2 months old;
3 M, 3 months old; 6 M, 6 months old.
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sodium valproate (200 mg/kg/day) once a day from day 60
to 66 post conception. VPA sodium salt (Sigma-Aldrich, St.
Louis, MO, United States) was dissolved in glucose just prior to
administration (Yasue et al., 2015, 2018; Mimura et al., 2019).
Perfusion Fixation and Preparation of
Marmoset Brain Sections
Animals at the ages indicated above were sedated with an
injection of ketamine hydrochloride (25 mg/kg, i.m.) following
an injection of atropine (0.15 µg/kg, i.m.). An overdose of
sodium pentobarbital (100 mg/kg i.p.; Somnopentyl, Kyoritsu
Seiyaku, Tokyo, Japan) was then administered. The animals were
perfused intracardially with 0.1 M potassium phosphate-buffered
saline (PBS) at pH 7.2 followed by 4% paraformaldehyde (PFA;
Merck, Whitehouse Station, NY, United States) in 0.1 M PBS
pH 7.2 (Mimura et al., 2019). The perfusion solutions were
delivered using a Masterflex 7553–7570 peristaltic pump (Cole-
Parmer, IL, United States). The perfused brains were removed
and incubated overnight in the PFA solution followed by a graded
series of sucrose solutions over 1 week at concentrations of
10, 20, and 30%. The brains were then sectioned 40 µm thick
using a sliding microtome (Retratome REM-710, Yamato Kohki
Industrial, Saitama, Japan).
Iba1 Immunohistochemistry
Iba1 is a calcium-binding protein expressed exclusively by
microglia in the CNS (Imai et al., 1996). Since Iba1 fills
the cytoplasm of microglia, immunohistochemical detection of
this protein is suitable for morphological studies of microglia
(Morgan et al., 2010). In this study, we selected sections from
area 12o in the prefrontal cortex for analysis because the 12o
area has been shown by PET to be the cortical area with
the highest [11C](R)—PK11195 binding potential, suggesting
that the area is expected to have activated microglia (Suzuki
et al., 2013). Endogenous peroxidase activity was blocked by
a 20-min incubation of the tissue sections in 80% methanol
containing 3% hydrogen peroxide. Next, sections were washed
three times with PBS containing 0.3% Triton X-100 (PBST).
After incubation in 1% bovine serum albumin (BSA; Sigma,
St. Louis, MO, United States) in PBST for 2 h, sections
were further incubated in rabbit anti-Iba1 primary antibody
(Wako, Osaka, Japan) diluted 1:1,000 in PBST containing
1% BSA at 4◦C overnight. After three washes with PBST,
sections were subjected to incubation for an additional 2 h
with biotinylated anti-rabbit IgG secondary antibody (Vector
Laboratories, Burlingame, CA, United States) diluted 1:200
in PBST containing 1% BSA at room temperature. Further,
sections were washed with PBS, and were incubated with
avidin-biotin-peroxidase complex solution (Vector Laboratories,
Burlingame, CA, United States) for 1.5–3 h. After three
washes, Iba1 positive structures were visualized using 3,3′-
diaminobenzidine tetrahydrochloride as a chromogen. The
sections were mounted on glass slides, dehydrated by graded
ethanol (25, 50, 70, and 100%), cleared by xylene, and then cover-
slipped (Entellan, Merck, Kenilworth, NJ, United States). Images
were captured using an All-in-One Fluorescence Microscope
(BZ-X700; KEYENCE, Osaka, Japan).
Immunofluorescent Staining for P2Y12
In addition to immunohistochemistry of Iba1, a cytosolic
microglial marker, we also prepared sections for
immunofluorescent staining for P2Y12, a microglia surface
marker (Wolf et al., 2017). After blocking non-specific binding
by incubating the sections for 2 h with PBST containing 1% BSA,
the sections were incubated with rabbit anti-P2Y12 primary
antibody (1:1000; Sigma-Aldrich, St. Louis, MO, United States)
in PBST containing 1% BSA at 4◦C overnight. The sections were
then washed extensively with PBST and incubated with secondary
antibody Alexa Fluor 488-conjugated anti-rabbit IgG (1:1000;
Invitrogen, Carlsbad, CA, United States) in PBST containing 1%
BSA at 4◦C for 2 h. After three washes, the sections were mounted
and cover-slipped using VECTASHIELD R© (Vector Laboratories,
Burlingame, CA, United States). Fluorescent images were
captured using an All-in-One Fluorescence Microscope. XY
images acquired at 1-µm z-step intervals were merged.
Analyses of Microglia Processes and
Cell Bodies and Microglia Density
First, we performed qualitative microscopic examination of
microglial morphology on tissues stained for Iba1 and P2RY12.
Then, quantitative analysis of morphology of microglial processes
and somata and microglial density was performed on sections
stained for Iba1.
For performing the quantitative analysis of morphology of
microglial processes and somata, 50 Iba1-positive microglia on
layer 3 of area 12o were selected from each animal used in
this study. Thus, the number of microglia examined both in
UE and VPA marmosets was 200 at 2M, 3M, 6M, and was
100 at adulthood. Selected microglial somata and corresponding
processes were traced three dimensionally by adjusting focal
plane through depth of each section using a Nikon ECLIPSE
80i microscope (Nikon, Tokyo, Japan) and the computer-aided
tracing system Neurolucida (MBF Bioscience, Williston, VM,
United States). We did not aim to complete reconstruction of
each microglia through multiple sections in order to acquire
global information of a single microglia as this was difficult due
to dense and clouded Iba1-positive processes in each section.
NeuroExplorer (MBF Bioscience, Williston, VT, United States),
which enabled us to quantify the length and width of microglial
processes and several indices of somata, was used for performing
the quantitative analysis.
Indices of the microglial processes quantified in this study
were (1) the number of thin (less than 0.15 µm) structures
segmenting microglia processes per cell, (2) the number of
processes directly deriving from a microglia soma, (3) the
total length of the processes belonging to microglia, (4) the
branching complexity of the processes, and (5) the diameter of
the processes. The total length of the Iba1-positive processes
was estimated using three-dimensional reconstructions (Oga
et al., 2013; Sasaki et al., 2015). The branching complexity
of the processes was examined using Sholl analyses (Sholl,
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1953); specifically, the number of Sholl annuli intersections was
quantified. The diameters of all processes were measured every
10 µm starting at 15 µm from the center of the cell body to avoid
mismeasurement of cell body per se.
The quantified factors regarding the cell bodies were (1)
the cell area and (2) the form factor. The form factor was
calculated using the equation (4π × area)/circumference2, as
described by Soltys et al. (2001). Thus, the maximum form factor
value of perfectly circular cells was 1 and activated microglia
had larger form factors than did microglia in a ramified state
(Soltys et al., 2001).
The solidity of the microglia was quantified as an
index of somata and processes (Soltys et al., 2001). The
solidity was calculated as the ratio between the cell and
convex area. The convex area was determined in two
dimensions as the area was found within a convex hull
traced around the outermost distal terminations (Oga
et al., 2013; Sasaki et al., 2015). Solidity was greater in
activated microglia than in microglia in a ramified state
(Soltys et al., 2001).
In addition, we performed analysis of microglial density.
For this purpose, the centers of the microglial cell bodies on
layer 3 of area 12o were located under a Nikon ECLIPSE 80i
microscope (Nikon, Tokyo, Japan) in ten Iba1-immunostained
sections from each animal used in this study, and the number of
microglia were counted in a 150 µm × 80 µm area. The density
value was expressed as the number of microglia cell bodies per
1000 µm2.
Statistical Analysis
The data were evaluated using analysis of variance (ANOVA)
followed by Tukey-Kramer post hoc tests. Statistical analyses
were performed using JSTAT software (Tokyo, Japan) and
KaleidaGraph 3.6 software (Synergy Software, Reading, PA,
United States). All values were expressed as the mean± STD and
p-values less than 0.05 were considered statistically significant.
RESULTS
Microglia Processes in VPA Marmosets
Were Segmented by Thin and Faintly
Iba1- and P2RY12-Positive Structures
Qualitative analysis of microglial processes on the tissues stained
for Iba1 and P2RY12 indicated that microglia processes
in VPA marmosets were frequently segmented by thin
(less than 0.15 µm diameter) and faintly immunopositive
structures, although the ones in UE marmosets were
rarely segmented (Figures 1A–C). The thin and faintly
immunopositive structures segmenting microglial processes
in VPA marmosets seemed to be thicker in sections stained
for P2RY12, a microglial surface marker, than in sections
stained for Iba1, a microglial cytosolic marker. Quantitative
analysis of the sections stained for Iba1 revealed that the
number of thin (less than 0.15 µm diameter) and faintly Iba1-
positive structures segmenting the processes of microglia was
FIGURE 1 | Segmented processes of microglia in VPA marmosets. (A) Representative images of Iba1-positive microglia at 3 months (M) in UE and VPA marmosets.
Arrowheads indicate thin and faintly Iba1-positive structures segmenting microglial processes. (B) Representative images of Iba1-positive microglia at 6 M in UE and
VPA marmosets. Arrowheads indicate thin and faintly Iba1-positive structures segmenting microglial processes. (C) Representative images of P2RY12-positive
microglia at 6 M in VPA marmosets. Arrows indicate segmented microglial processes. Inset corresponds to the enlarged image of (C). Arrowheads in inset indicate
thin delicate processes bridging P2RY12-positive microglial processes. (D) Histogram shows the number of thin (less than 0.15 µm) and faintly Iba1-positive
structures segmenting microglial processes in UE and VPA marmosets through the developmental stages examined. ∗p < 0.05, ∗∗p < 0.01. The bars indicate 5 µm.
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FIGURE 2 | Morphological changes of microglial processes in developmental VPA marmosets assayed on sections stained for Iba1. (A) Histogram shows the
number of microglial processes directly deriving from a soma in UE and VPA marmosets through developmental stages examined. (B) Histogram shows the total
length of microglial processes of a microglia in UE and VPA marmosets through developmental stages examined. (C) Line graphs show the number of intersections
of microglial processes and concentric circle denotes microglia in UE and VPA marmosets in each developmental stage examined. (D) Histograms show the diameter
of microglia at every 10 µm distance from the center of a cell body in UE and VPA marmosets of each developmental stage examined. ∗p < 0.05, ∗∗p < 0.01.
statistically higher in VPA marmosets than in UE marmosets
throughout the ages evaluated (Figure 1D). This number
progressively increased along with developmental ages in VPA
marmosets (Figure 1D).
Differential Morphology of Microglia
Processes and Somata Between VPA
and UE Marmosets on the Tissues
Stained for Iba1
The number of processes directly deriving from a microglial
soma in VPA marmosets was statistically lesser than that in UE
marmosets only in the adult animals (Figure 2A). The total
length of the processes did not statistically differ between UE and
VPA marmosets (Figure 2B). The complexity of the processes
as represented by the number of intersections of Sholl annuli
also did not differ between the two marmosets (Figure 2C).
The diameter of the distal part of the microglial processes at
6 months and in adult marmosets was statistically smaller in VPA
marmosets than in UE marmosets (Figure 2D).
There was no significant difference in the area of the microglia
cell bodies for UE marmosets compared to that for VPA
marmosets (Figure 3A). In contrast, the form factor of the cell
bodies at 3 and 6 months, and adulthood was greater in VPA
marmosets than in UE marmosets (Figure 3B). The solidity of
the microglia was statistically lower in VPA marmosets than in
UE marmosets at 3 and 6 months of age (Figure 3C).
Distribution of Microglia in VPA and UE
Marmosets on the Sections Stained for
Iba1
The density of microglia cell bodies in VPA marmosets at
6 months was statistically lower than that in UE marmosets
FIGURE 3 | Morphological changes of microglial cell bodies and an index for
microglial somata and processes (i.e., solidity) in VPA marmosets assayed on
sections stained for Iba1. (A) Histogram shows the area of microglial cell body
in UE and VPA marmosets through the developmental stages examined.
(B) Histogram shows the area of microglial cell body in UE and VPA
marmosets through the developmental stages examined. (C) Histogram
shows the solidity of a microglia in UE and VPA marmosets through the
developmental stages examined. ∗p < 0.05.
(Figure 4). There were no statistical differences at any
other ages evaluated.
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FIGURE 4 | Effects of prenatal exposure to VPA on microglial density in marmoset cortex assayed on sections stained for Iba1. (A) Representative images show
microglial distribution in UE and VPA marmosets through the developmental stages examined. (B) Histogram shows the density of microglia in UE and VPA
marmosets through the developmental stages examined. ∗p < 0.05. Bar indicates 100 µm.
DISCUSSION
In the current study, we performed qualitative and quantitative
analysis of microglia in VPA marmosets with autistic behavior
and UE marmosets at the ages from early toddler to adulthood on
the sections stained for Iba1, and P2RY12. Quantitative analysis
on the tissue stained for Iba1 showed that most of the parameters
evaluated demonstrated age-dependent differences. However, the
number of thin and faintly Iba1-positive structures segmenting
the microglial processes was robustly greater in VPA marmosets
than in UE marmosets throughout the evaluated life span. This
microglia segmentation seemed to be a hallmark of the VPA
marmoset cortex.
Comparison of Segmented Microglia
Processes in the Marmoset Model of
ASD to Those in Humans With ASD and
Mice With Autistic Behaviors
Morgan et al. (2010) reported that microglia of some
patients with ASD had altered morphology based on Iba1
immunohistochemistry. They provided images of segmented
microglia processes in the cerebral cortex of 3-year old, 7-year
old, and adult patients with ASD. The microglia processes in
the control cases did not exhibit segmentation. In a mouse
model of fragile X syndrome with autistic behaviors (Fmr1-KO
mice), Jawaid et al. (2018) presented an image of segmented
microglia processes in the hippocampus of 3-week old mice.
Interestingly, “beads-on-string” structures resembling segmented
microglial processes in patients and model animals with ASD
symptoms were also found to be present in cells undergoing
apoptosis (Atkin-Smith et al., 2015; Atkin-Smith and Poon,
2017). It has been reported that, under some pathological
conditions, microglia show higher turnover, and that proliferated
microglia are removed partly by a mechanism of apoptosis
(Füger et al., 2017; Tay et al., 2017). Thus, it is possible that
microglia with segmented processes found in this study might be
in the apoptotic phase with high turnover rate of microglia. This
possibility should be tested in a future study.
Other Indices of Microglia Cell Bodies
and Processes, and Microglia Density in
VPA Marmosets
Classically, activated microglia are morphologically characterized
as having larger cell somata, fewer processes directly deriving
from their cell bodies, and less complex arborization of their
processes compared to microglia in a resting state (Streit et al.,
1988; Graeber and Streit, 2010). In the current study, we observed
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that the microglia in VPA marmosets had larger somata and
fewer processes, which were directly deriving from their somata,
compared to those in UE marmoset only in adulthood. Moreover,
Sholl analysis revealed that differences in the complexity of
processes between UE and VPA marmosets were not statistically
significant throughout the life span evaluated. Thus, in a classical
definition, we were unable to conclude whether the microglia
in VPA marmosets were either activated or in a resting state.
Soltys et al. (2001) found that two morphological markers, the
form factor and solidity, can be useful for discriminating between
activated bushy cells and resting ramified cells. Both form factor
and solidity in activated microglia have been shown to be larger
than those in resting microglia (Soltys et al., 2001). In our study,
the form factor of microglia from late toddler to adulthood was
larger in VPA marmosets than in UE marmosets, and the solidity
of microglia in late toddler to early adolescence was smaller
in VPA marmosets than in UE marmosets. These findings are
consistent with microglia morphology dependent upon brain
disorders, including ASD, being reconceptualized as the result
of aberrations in the physiological and homeostatic functions
of microglia (Salter and Stevens, 2017; Wolf et al., 2017; Tay
et al., 2018). In addition, throughout the life span evaluated
in our study, microglia processes in VPA marmosets tended to
be thinner than those in UE marmosets with the differences
being statistically significant in early adolescence and adulthood.
In VPA marmosets, thinning microglia processes along with
development seemingly paralleled the increasing number of
thin and faintly Iba1-positive structures segmenting microglia
processes with the passage of age.
Previous studies showed that microglia density tends to be
higher in patients with ASD than in typically developed cases
(Morgan et al., 2010). However, similar to our results, microglia
density in rats prenatally exposed to VPA is statistically lower in
later life than in control rats (Bronzuoli et al., 2018). In the future,
these results need to be re-considered in the context of other
factors, such as altered microglial and neuronal proliferation rates
(Courchesne et al., 2007; Morgan et al., 2012; Füger et al., 2017;
Tay et al., 2017) and neuropil expansion as a result of increased
dendritic spine density (Hutsler and Zhang, 2010; Penzes et al.,
2011; Tang et al., 2014), both of which are found in ASD patients.
In summary, since segmentation of microglia processes occurs
in patients with ASD and in rodent and marmoset models of ASD,
this feature may serve as a good biomarker for assessing brain
pathology, and the healing effects of ASD therapy.
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